Broad syntheses related to this topic

loading
6 References (6 articles) loading Revert Studify

Broad synthesis

Unclassified

The blind men and the elephant: Systematic review of systematic reviews of cannabis use related health harms.

blocked
Journal European Neuropsychopharmacology
Year 2020
Links Pubmed DOI

This article includes 43 Systematic reviews Systematic reviews (43 references)

Loading references information
ABSTRACT: Cannabis is the third most used psychoactive substance worldwide. The legal status of cannabis is changing in many Western countries, while we have very limited knowledge of the public health impact of cannabis-related harms. There is a need for a summary of the evidence of harms and risks attributed to cannabis use, in order to inform the definition of cannabis risky use. We have conducted a systematic review of systematic reviews, aiming to define cannabis-related harms. We included systematic reviews published until July 2018 from six different databases and following the PRISMA guidelines. To assess study quality we applied the AMSTAR 2 tool. A total of 44 systematic reviews, including 1,053 different studies, were eligible for inclusion. Harm was categorized in three dimensions: mental health, somatic harm and physical injury (including mortality). Evidence shows a clear association between cannabis use and psychosis, affective disorders, anxiety, sleep disorders, cognitive failures, respiratory adverse events, cancer, cardiovascular outcomes, and gastrointestinal disorders. Moreover, cannabis use is a risk factor for motor vehicle collision, suicidal behavior and partner and child violence. Cannabis use is a risk factor for several medical conditions and negative social consequences. There is still little data on the dose-dependency of these effects; evidence that is essential in order to define, from a public health perspective, what can be considered risky use of cannabis. This definition should be based on quantitative and qualitative criteria that informs and permits the evaluation of current approaches to a regulated cannabis market. (PsycINFO Database Record (c) 2020 APA, all rights reserved)

Broad synthesis / Overview of systematic reviews

Unclassified

Adverse Effects of Cannabis Use on Neurocognitive Functioning: A Systematic Review of Meta- Analytic Studies.

blocked
Journal Journal of dual diagnosis
Year 2020
Links Pubmed DOI PubMed Central

This article includes 10 Systematic reviews Systematic reviews (10 references)

Loading references information
Objective: As the perceived risk of cannabis use continues to decline among youths and access continues to increase, it has become more important to synthesize the rapidly growing literature on the effects of cannabis on neurocognition. Hundreds of studies examining associations between cannabis use and neurocognitive functioning have been published in recent decades. However, results often differ across individual studies, particularly when sample sizes are small. Meta-analytic methods help to make sense of this literature and have been increasingly applied to studies on cannabis use and neurocognition. Methods: A systematic literature search using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines was conducted to identify peer-reviewed meta-analyses of neurocognitive or functional neuroimaging data that examined associations between cannabis use and non-acute effects on neurocognitive functioning (n = 8). Results: Current findings suggest that regular healthy cannabis users, regardless of age, display poorer neurocognitive functioning relative to nonusers of small to medium effect sizes across many neurocognitive domains, as well as functional brain alterations when compared to non-users. Adverse effects are not uniform across neurocognitive domains and evidence for adolescent-onset users having poorer neurocognitive outcomes remains equivocal based on these studies. However, less is known about cannabis effects on neurocognition among clinical samples, as findings from specific clinical samples revealed mixed results. Conclusions: Meta-analyses have played an important role in helping to grasp the totality of results from a large body of literature on cannabis effects on neurocognition, yet more research (particularly large-scale longitudinal studies) is needed to identify critical periods or patterns of use that are more likely to result in negative outcomes.

Broad synthesis

Unclassified

Cannabis for Medical Use - A Scientific Review

blocked
Report HPRA
Year 2017
Links health.gov.ie

This article includes 6 Primary studies Primary studies (6 references) 15 Systematic reviews Systematic reviews (15 references)

Loading references information

Broad synthesis

Unclassified

Cannabis: The Evidence for Medical Use

blocked
Authors Barnes, MP , Barnes, JC
Report Group for Drug Policy Reform
Year 2016

This article includes 124 Primary studies Primary studies (124 references) 25 Systematic reviews Systematic reviews (25 references)

Loading references information

Broad synthesis

Unclassified

Update of cannabis and its medical use

blocked
Authors Madras, Bertha K
Report Report to the WHO Expert Committee on Drug Dependence
Year 2015
Links who.int

This article includes 128 Primary studies Primary studies (128 references) 33 Systematic reviews Systematic reviews (33 references)

Loading references information

Broad synthesis / Overview of systematic reviews

Unclassified

An overview of systematic reviews on cannabis and psychosis: discussing apparently conflicting results.

Journal Drug and alcohol review
Year 2010
Links Pubmed DOI

This article includes 5 Systematic reviews Systematic reviews (5 references)

Loading references information
ISSUES: Cross-sectional surveys have revealed that cannabis is the most widely used illicit substance in Western countries. Cannabis intoxication can lead to acute, transient psychotic symptoms and the short-term exacerbation of pre-existing psychotic symptoms. However, controversy exists about whether cannabis can actually cause long-term psychosis. APPROACH: We summarised the findings of systematic reviews on the association between cannabis use and psychosis, searching MEDLINE, EMBASE and CINAHL up to August 2007. We assessed the methodological quality, selected the better quality reviews and analysed reasons for discordant results. KEY FINDINGS: We included five systematic reviews. Four of the reviews performed a meta-analysis and showed a consistent association between cannabis use and psychosis; the fifth review considered psychological problems more broadly, did not perform a meta-analysis and reported an inconsistent association. The reasons for discordance were: different outcomes (psychosis vs. psychological problems), different inclusion criteria for primary studies and different methods for summarising the results. IMPLICATIONS: This overview shows a consistent association between cannabis use and psychotic symptoms, though it is not possible to draw firm conclusions about a causal relationship. Reverse causality and residual confounding cannot be excluded. An interaction with other environmental and genetic factors is difficult to ascertain. CONCLUSION: We conclude that there is insufficient knowledge to determine the level of risk associated with cannabis use in relation to psychotic symptoms and that more information is needed on both the risks of cannabis use and the benefits of preventive interventions to support evidence-based approaches in this area.